Skip to main content
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center

News releases

September 2016arrow

Lam obtains major federal grants

September 23, 2016

Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has received two major cancer research grants totaling more than $3 million.

Kit Lam appointed to NCI Board of Scientific Counselors

September 20, 2016

Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has been appointed to the National Cancer Institute’s Basic Science Board of Scientific Counselors (BSC).

Voices of patients and oncologists must be heard, study shows

September 9, 2016

Training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology.

Ovarian cancer event ready to "ROC" Sept. 18

September 8, 2016

Marking Ovarian Cancer Awareness Month and the need for more research and education about the disease, Let’s ROC, the annual 5K run is set for Sunday, Sept. 18 at 8 a.m.

Cancer Center oral therapy adherence program wins Innovative Pharmacy Practice Award

September 7, 2016

The cancer center's pharmacist-driven oral anti-cancer medication adherence program, led by Iris C. Zhao, has earned the 2016 California Society of Health System Pharmacist’s (CSHP) Innovative Pharmacy Practice Award.

UC Davis K12 scholars funded for cancer research

September 6, 2016

The National Cancer Institute has again funded the K12 Paul Calabresi Clinical Oncology Training Grant to promote and sustain the development of young cancer scientists from diverse fields and from laboratories and clinics across both UC Davis campuses.

August 2016arrow

IPHI report shows impact of cancer screening in California over past 15 years

August 31, 2016

A new report from the UC Davis Institute for Population Health Improvement (IPHI) shows the impact of cancer screening over the past 15 years, identifying areas where increased screening and other cancer-control efforts would save lives and significantly benefit population health.

Lay educators help boost colorectal screening rates in Hmong

August 26, 2016

Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.

UC Davis among the top for cancer, again

August 22, 2016

Becker’s Hospital Review has named UC Davis Health System one of 100 in the country with “great oncology programs.”

UC Davis scientists awarded $1 million grant for prostate cancer research

August 5, 2016

The Prostate Cancer Foundation and Movember, the global charity that has raised hundreds of millions for men’s health research and programs, have delivered $1 million to UC Davis prostate cancer researchers.

July 2016arrow

Hybrid treatment hunts down and kills leukemia cells

July 28, 2016

Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.

De Vere White to serve on prestigious NIH panel

July 26, 2016

Ralph de Vere White, who retired in June as director of the UC Davis Comprehensive Cancer Center, has been named to a key committee at the National Institute of Health (NIH).

Player-in-chief

July 21, 2016

The play area in the pediatric infusion center is buzzing with activity. Kids are building, coloring, reading and, most importantly, laughing. Not just patients, but parents and siblings, too. The play area isn’t just a haphazard jumble of donated toys and books, it’s a space specially designed by the cancer center’s resident child life specialist and expert on fun, Ellen Meuchel.

Oncologists and cancer patients often differ in prognosis perceptions

July 14, 2016

Patients with stage III or IV cancer report far more optimistic expectations for survival than their oncologists thought they had communicated, according to new research published today in JAMA Oncology. Effective communication between doctors and their patients who could be nearing the end of their lives is crucial, according to the authors, since this is when quality-of-life decisions merge with discussions about treatment options.

Lily Chiquet Strength Foundation, Inc. honors memory of child with donation

July 14, 2016

Lily Chiquet would have been 4 this week.

June 2016arrow

Endowment for promising students honors de Vere White

June 29, 2016

Ralph de Vere White, who steps down this week after a 32-year career at UC Davis Health System, has been honored with an educational endowment in his name.

Lung cancer patients who have surgery live longer

June 7, 2016

Patients with late-stage, non-small cell lung cancer (NSCLC) who have surgery have better survival rates than those who don’t, but fewer of these patients are undergoing surgery, UC Davis researchers have found.

May 2016arrow

De Vere White to step down as long-time UC Davis Comprehensive Cancer Center director

May 31, 2016

Ralph de Vere White, a beloved urologist and acclaimed researcher who led the UC Davis Comprehensive Cancer to designation by the National Cancer Institute (NCI), steps down as its long-time director on June 29.

Miglioretti awarded $7.5 million to evaluate supplemental breast imaging

May 25, 2016

Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies -- digital breast tomosynthesis (3D mammography) and magnetic resonance imaging (MRI) -- used with mammography for cancer detection. Miglioretti’s team also will work to determine whether effectiveness of the screening strategies depends on a woman’s breast density.

National Cancer Institute re-designates the cancer center

May 17, 2016

The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves.

Autism and cancer share a remarkable number of risk genes in common

May 3, 2016

Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.

Common supplement boosts kidney cancer therapy

May 2, 2016

Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the May issue of the journal Molecular Cancer Therapeutics.

Targeted hepatitis B virus screening effective in addressing infection, liver disease risk

May 2, 2016

A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer.

April 2016arrow

SU2C awards Albeck Innovative Research Grant

April 26, 2016

UC Davis molecular biologist John Albeck is among 10 recipients chosen to receive a 2016 Innovative Research Grant (IRG) from Stand Up to Cancer (SU2C), a non-profit that supports innovative, high-risk, high-reward projects to accelerate the pace of cancer research and give patients access to new therapies as quickly as possible.

UC Davis Comprehensive Cancer Center earns new quality certification

April 20, 2016

The UC Davis Comprehensive Cancer Center’s Division of Hematology/Oncology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program for meeting the nation’s highest quality standards for cancer care.

UC Davis expands surgical care for lower GI diseases

April 20, 2016

Linda Farkas, a surgeon and expert in hereditary cancers, has joined UC Davis Health System as a professor of surgery and chief of the newly created Division of Colon and Rectal Surgery.

International Cancer Genome Consortium for Medicine launch announced

April 17, 2016

The International Cancer Genome Consortium (ICGC) today announced plans to launch of the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the consortium’s evolution that will link genomics to clinical information and health.

Radiation improves survival in older patients with soft tissue sarcomas

April 11, 2016

UC Davis researchers have shown that radiation therapy following surgery benefits older patients more than their younger counterparts, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS).

March 2016arrow

New target makes end run against therapy-resistant prostate cancer

March 28, 2016

Researchers at UC Davis, in collaboration with the other institutions, have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth.

State stem cell agency approves research funding for UC Davis scientists

March 21, 2016

Two new UC Davis research efforts, one aimed at addressing fatal early childhood conditions known as Tay-Sachs and Sandhoff disease, the other designed to develop an immunotherapy that would eradicate solid tumor cancer stem cells and create sustained anti-tumor effects, have been approved for funding by the California Institute for Regenerative Medicine (CIRM).

February 2016arrow

Two UC Davis pediatric oncology patients meet princesses at Disney on Ice

February 24, 2016

Two UC Davis Children’s Hospital and UC Davis Comprehensive Cancer Center patients had the chance to forget about cancer treatments for an evening and meet Princess Anna and Princess Elsa from Frozen at recent Disney On Ice performances. 

"Coloring therapy" helps ease patients' stress

February 24, 2016

Sandy Gantt receives infusions of chemotherapy to treat her leukemia for hours on end, day after day. But she’s found one thing that transports her from that reality to a less stressful place.

Patient coordinator to go bald to help kids with cancer

February 24, 2016

It can’t be easy parting with a head of beautiful long, dark hair. But that’s exactly what Venessa Garcia plans to do. A patient care coordinator at UC Davis Comprehensive Cancer Center, Garcia will undergo the razor treatment March 14 during the annual St. Baldrick’s Foundation event for pediatric cancer research.

Finding new targets to battle drug resistance

February 1, 2016

Researchers at UC Davis and Lawrence Livermore and Los Alamos national laboratories have created a chemotherapy-resistant line of bladder cancer cells to study how tumors become resistant to chemotherapy and identified molecular changes that could drive that resistance.

January 2016arrow

Young, poor African Americans and Hispanics have harder time beating Hodgkin Lymphoma

January 29, 2016

African American and Hispanic adolescents and young adults fare far worse than their white counterparts when faced with a mostly curable type of cancer, Hodgkin lymphoma, a study by a UC Davis epidemiologist has found.

Melnikow appointed to expert panel of the Institute for Clinical and Economic Review

January 22, 2016

UC Davis physician and health policy expert Joy Melnikow has been appointed to the panel of the California Technology Assessment Forum of the Institute for Clinical and Economic Review.

More research needed on evaluation of dense breasts

January 11, 2016

A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next.

Making a safe procedure even safer

January 11, 2016

In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women.

Women recognize UC Davis as one of America's best hospitals for bariatric surgery, cancer and heart care

January 8, 2016

UC Davis Medical Center has received the 2016 Women’s Choice Award as one of America’s best hospitals for bariatric surgery, cancer and heart care.

December 2015arrow

It takes a UC village: Smoking cessation push goes high tech

December 23, 2015

Buster Halcomb was just 5, a scruffy shoeshine boy in a billiard hall in Cumberland, Ky., when three men approached with packs of “tailor-made” cigarettes.

A visit to the gas station: Protein helps power up DNA repair

December 3, 2015

In a game-changing study, researchers at UC Davis and other organizations have shown that the enzyme cyclin-dependent kinase 1 (CDK1), which plays a key role in DNA repair, also leaves the nucleus to boost cellular energy production. By irradiating normal cells, the team showed that CDK1 turned up production of ATP, cellular energy packets that – in this case – provided the necessary power supply to fix the radiation-damaged DNA.

November 2015arrow

Lam receives $4 million in NIH grants for novel cancer research

November 18, 2015

Kit Lam, professor and chair of the Department of Biochemistry and Molecular Medicine, has been awarded two major, multi-disciplinary U01 grants from the National Institutes of Health (NIH), the first to investigate use of a new tool to visualize cancer tumor growth and response to nanoparticle drugs, and the other to develop a new 4-D imaging tool to advance the understanding of how the nucleus functions in living cells.

Small RNA has big impact on prostate cancer

November 17, 2015

Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.

Kelly takes the reins of prestigious SWOG Lung Committee

November 4, 2015

Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been named chair of the Lung Committee of SWOG, one of the nation’s leading cooperative cancer research organizations.